About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Early Support After Exposure to Trauma | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT06592677

Early Support After Exposure to Trauma

A significant proportion of people who are exposed to traumatic events suffer from post-traumatic sequelae, such as post-traumatic stress disorder (PTSD). Indicated preventive interventions soon after...

Lead sponsor: Norwegian Center for Violence and Traumatic Stress Studies•29 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Harald Bækkelund, PhD

CONTACT

+47 90964268 harald.bakkelund@nkvts.no

Marianne S Birkeland, PhD

CONTACT

+47 41433496 m.s.birkeland@nkvts.no

Sponsors

Lead Sponsor

Norwegian Center for Violence and Traumatic Stress Studies

Collaborators

Regional Centre - Violence, Trauma and Suicide Prevention - Region East (RVTS-East)
NORCE Norwegian Research Centre AS
Karolinska Institutet
The Research Council of Norway

Age

16 - 99 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Receives support from a municipal crisis team
•Exposure to a traumatic event (as defined by criteria A for the diagnosis of post-traumatic stress disorder (PTSD) in the DSM-5) within the last seven weeks before randomization
•A total score of 10 or above on the PTSD Symptom Checklist-5 at the time of randomization
•Age 16 or above
•Written informed consent
•Writes and speaks English and/or Norwegian

Exclusion Criteria

•Severe psychopathology in need of specialized health care (e.g., psychotic symptoms, or high suicide risk) or substance dependence syndrome in need of specialized health care
•Known or evident severe cognitive impairment
•Ongoing traumatization, violence, or threats
•Unstable dose of psychotropic medication two weeks prior to randomization
•Concurrent therapy elsewhere before randomization

Related studies

Predictability of the Clinical Global Impression Scale (CGI) in Post Immediate in Psychotraumatic Impact

NCT05358067 · Post-traumatic Stress Disorder

Recovering Sleep After Trauma

NCT07196332 · Post-traumatic Stress Disorder

Psychotherapy Effects on Reward Processing in PTSD

NCT06096740 · Post Traumatic Stress Disorder, Diminished Pleasure, and more

Approach-Avoidance and Alcohol Challenge Study in PTSD

NCT06002633 · Post-Traumatic Stress Disorder, Alcohol Drinking

Interest of Cardiac Coherence in the Prevention of Chronic Post-traumatic Stress Disorder: Pilot Study

NCT04701723 · Post-traumatic Stress Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 23, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment360

Start dateSep 2024

Last updatedMar 23, 2026

Condition

Post-traumatic Stress Disorder

Locations shown

Asker municipality - Psychosocial crisis team

Asker, Asker

Psychosocial crisis team - Indre Østfold kommune

Askim, Askim

Psychosocial crisis team - Oslo, St Hanshaugen

Oslo, Oslo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 23, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions